Xiao Kun, Zhao Fei, Liu Qiang, Jiang Jinliang, Chen Zhiyong, Gong Wei, Zheng Zengwang, Le Aiping
Department of Blood Transfusion, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China (mainland).
Department of Neurology, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China (mainland).
Med Sci Monit. 2020 Nov 7;26:e923448. doi: 10.12659/MSM.923448.
BACKGROUND The aim of this study was to investigate the effects of red blood cell (RBC) storage duration on the outcomes of adult isolated traumatic brain injury (iTBI) patients after transfusion. MATERIAL AND METHODS A total of 1252 adult iTBI patients who received the fresh RBCs (stored for £14 days) or old RBCs (stored for >14 days) were finally enrolled in this study. The primary outcome was 90-day mortality. The secondary outcomes were in-hospital mortality, nosocomial infection, and complications. RESULTS By 90 days after RBC transfusion, 89 patients (17.0%) had died in the fresh RBC group, and 107 had died (14.7%) in the old RBC group, with no significant difference in 90-day mortality between the 2 groups (OR=1.192, 95% CI: 0.877-1.620, P=0.261). According to ISS score, no differences were discovered in mild injury (OR=1.079, 95% CI: 0.682-1.707, P=0.746), severe injury (OR=1.055, 95% CI: 0.634-1.755, P=0.838), and more severe injury (OR=1.940, 95% CI: 0.955-3.943, P=0.064). For GCS score, there were no differences in mild injury (OR=1.546, 95% CI: 0.893-2.676, P=0.118), moderate injury (OR=0.965, 95% CI: 0.616-1.513, P=0.877), and severe injury (OR=1.332, 95% CI: 0.677-2.620, P=0.406). We also observed no significant differences in secondary outcomes. CONCLUSIONS Use of old RBCs did not increase the 90-day mortality in adult iTBI patients.
背景 本研究旨在调查红细胞(RBC)储存时间对成年孤立性创伤性脑损伤(iTBI)患者输血后结局的影响。
材料与方法 本研究最终纳入了1252例接受新鲜红细胞(储存时间≤14天)或陈旧红细胞(储存时间>14天)的成年iTBI患者。主要结局为90天死亡率。次要结局为住院死亡率、医院感染和并发症。
结果 红细胞输血后90天,新鲜红细胞组有89例患者(17.0%)死亡,陈旧红细胞组有107例患者(14.7%)死亡,两组90天死亡率无显著差异(OR=1.192,95%CI:0.877-1.620,P=0.261)。根据损伤严重度评分(ISS),轻度损伤(OR=1.079,95%CI:0.682-1.707,P=0.746)、重度损伤(OR=1.055,95%CI:0.634-1.755,P=0.838)和极重度损伤(OR=1.940,95%CI:0.955-3.943,P=0.064)之间均未发现差异。对于格拉斯哥昏迷量表(GCS)评分,轻度损伤(OR=1.546,95%CI:0.893-2.676,P=0.118)、中度损伤(OR=0.965,95%CI:0.616-1.513,P=0.877)和重度损伤(OR=1.332,95%CI:0.677-2.620,P=0.406)之间也未发现差异。我们还观察到次要结局无显著差异。
结论 使用陈旧红细胞不会增加成年iTBI患者的90天死亡率。